Non-Current Assets

Equity Method Investments

Palantir Technologies Inc. Equity Method Investments increased by 32.8% to $163.20M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 210.3%, from $52.60M to $163.20M.

Analysis

StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ4 2025

How to read this metric

An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.

Detailed definition

These are investments in entities where the company exercises significant influence but does not have full control. The...

Peer comparison

Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.

Metric ID: equity_method_investments

Historical Data

8 periods
 Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25
Value$32.60M$35.10M$49.90M$52.60M$64.90M$104.50M$122.90M$163.20M
QoQ Change+7.7%+42.2%+5.4%+23.4%+61.0%+17.6%+32.8%
YoY Change+99.1%+197.7%+146.3%+210.3%
Range$32.60M$163.20M
CAGR+151.0%
Avg YoY Growth+163.3%
Median YoY Growth+172.0%
Current Streak7+ quarters growth

Frequently Asked Questions

What is Palantir Technologies Inc.'s equity method investments?
Palantir Technologies Inc. (PLTR) reported equity method investments of $163.20M in Q3 2025.
How has Palantir Technologies Inc.'s equity method investments changed year-over-year?
Palantir Technologies Inc.'s equity method investments increased by 210.3% year-over-year, from $52.60M to $163.20M.
What does equity method investments mean?
The value of investments in other companies where the firm has significant influence but not total control.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.